Literature DB >> 16570920

Development of a structural model for NF-kappaB inhibition of sesquiterpene lactones using self-organizing neural networks.

Steffen Wagner1, Angelika Hofmann, Bettina Siedle, Lothar Terfloth, Irmgard Merfort, Johann Gasteiger.   

Abstract

A variety of sesquiterpene lactones (SLs) possess considerable anti-inflammatory activity. Several studies have shown that they exert this effect in part by inhibiting the activation of the transcription factor NF-kappaB. In the present study we elaborated on the investigation of a data set of 103 structurally diverse SLs for which we had previously developed several different QSAR equations dependent on the skeletal type. Use of 3D structure descriptors resulted in a single model for the entire data set. In particular, local radial distribution functions (L-RDF) were used that centered on the methylene-carbonyl substructure believed to be the site of attack of cysteine-38 of the p65/NF-kappaB subunit. The model was developed by using a counterpropagation neural network (CPGNN), attesting to the power of this method for establishing structure-activity-relationships. The investigations shed more light onto the influence of the chemical structure on NF-kappaB inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16570920     DOI: 10.1021/jm051125n

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

1.  An allenic Pauson-Khand approach to 6,12-guaianolides.

Authors:  Francois Grillet; Chaofeng Huang; Kay M Brummond
Journal:  Org Lett       Date:  2011-11-09       Impact factor: 6.005

2.  Cytotoxic and NF-κB inhibitory sesquiterpene lactones from Piptocoma rufescens.

Authors:  Yulin Ren; Ulyana Muñoz Acuña; Francisco Jiménez; Ricardo García; Melciades Mejía; Heebyung Chai; Judith C Gallucci; Norman R Farnsworth; Djaja D Soejarto; Esperanza J Carcache de Blanco; A Douglas Kinghorn
Journal:  Tetrahedron       Date:  2012-01-26       Impact factor: 2.457

Review 3.  Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

Authors:  Subash C Gupta; Chitra Sundaram; Simone Reuter; Bharat B Aggarwal
Journal:  Biochim Biophys Acta       Date:  2010-05-21

Review 4.  Modeling chemical reactions for drug design.

Authors:  Johann Gasteiger
Journal:  J Comput Aided Mol Des       Date:  2007-01-25       Impact factor: 3.686

5.  Halocarbocyclization entry into the oxabicyclo[4.3.1]decyl exomethylene-δ-lactone cores of linearifolin and zaluzanin A: exploiting combinatorial catalysis.

Authors:  Sandeep K Ginotra; Jacob A Friest; David B Berkowitz
Journal:  Org Lett       Date:  2012-02-08       Impact factor: 6.005

Review 6.  Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones.

Authors:  Yulin Ren; Jianhua Yu; A Douglas Kinghorn
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

7.  Goyazensolide Induces Apoptosis in Cancer Cells in vitro and in vivo.

Authors:  Ulyana Muñoz Acuña; Qi Shen; Yulin Ren; Daniel D Lantvit; Jennifer A Wittwer; A Douglas Kinghorn; Steven M Swanson; Esperanza J Carcache de Blanco
Journal:  Int J Cancer Res       Date:  2013

Review 8.  Potential roles of the NFκB and glutathione pathways in mature human erythrocytes.

Authors:  Mehrdad Ghashghaeinia; Mahmoud Toulany; Mohammad Saki; H Peter Rodemann; Ulrich Mrowietz; Florian Lang; Thomas Wieder
Journal:  Cell Mol Biol Lett       Date:  2011-11-21       Impact factor: 5.787

9.  Bcl-XL, but not Bcl-2, can protect human B-lymphoma cell lines from parthenolide-induced apoptosis.

Authors:  Alan T Yeo; John A Porco; Thomas D Gilmore
Journal:  Cancer Lett       Date:  2011-12-06       Impact factor: 8.679

10.  The natural sesquiterpene lactones arglabin, grosheimin, agracin, parthenolide, and estafiatin inhibit T cell receptor (TCR) activation.

Authors:  Igor A Schepetkin; Liliya N Kirpotina; Pete T Mitchell; Аnarkul S Kishkentaeva; Zhanar R Shaimerdenova; Gayane A Atazhanova; Sergazy M Adekenov; Mark T Quinn
Journal:  Phytochemistry       Date:  2017-12-22       Impact factor: 4.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.